Graebert K S, Lemansky P, Kehle T, Herzog V
Institute of Cell Biology, Rheinische-Friedrich-Wilhelms Universität Bonn, Germany.
Lab Invest. 1995 May;72(5):513-23.
Dysregulation in the processing of the Alzheimer precursor protein (APP) is thought to be central to the deposition of the beta-A4 peptide and to the pathogenesis of Alzheimer's disease. Expression and release of APP has also been known to mediate cell-matrix interactions and to participate in the regulation of cell proliferation. It has also been shown that APP is a member of a family of closely related proteins. This family comprises different splice-forms of APP and APP-like proteins (APP/APLP). Because of the specific processing of exportable proteins, thyrocytes represent a particularly useful cell type for the study of the processing of APP/APLP (especially proteolysis and iodination) as an indication of cell surface expression and for the study of the regulation of these functions.
Rats were treated in vivo with propylthiouracil, which is known to cause a rise of serum thyroid-stimulating hormone (TSH) levels and maximum stimulation of thyroid function and growth. The expression of APP/APLP was analyzed in rat thyroid tissue and in a continuous cell line (FRTL-5) by immunofluorescence staining and by sodium dodecyl sulfate polyacrylamide gel electrophoresis and immunoblotting. Using FRTL-5 cells, secretion and turnover were analyzed by biosynthetic radiolabeling and immunoprecipitation of APP/APLP.
APP/APLP was detected in follicle cells and in the follicle lumen of resting thyroid glands. In propylthiouracil-treated rats, the complete endocytic removal of the luminal content coincided with the pronounced visualization of APP/APLP in the extrafollicular space, where it was associated with proliferating endothelial cells and fibroblasts. In FRTL-5 cells, APP/APLP was localized mainly in the Golgi complex and in compartments along the endocytic pathway, including lysosomes, where degradation of APP/APLP occurred. Mature and immature forms of APP/APLP became iodinated upon reaching the plasma membrane. Part of the extracellular portion of APP/APLP was released by these cells into the culture medium by TSH-dependent cleavage and secretion mechanisms.
The observations show the expression, maturation, and secretion of APP/APLP in thyrocytes and the up-regulation of these processes by TSH. Part of the immature APP/APLP appeared on the cell surface as indicated by its iodination. Apparently, this portion of immature APP/APLP escaped maturation during its transport to the cell surface.
阿尔茨海默病前体蛋白(APP)加工过程中的失调被认为是β - A4肽沉积及阿尔茨海默病发病机制的核心。已知APP的表达和释放介导细胞 - 基质相互作用并参与细胞增殖的调节。还表明APP是一个紧密相关蛋白家族的成员。该家族包括APP的不同剪接形式和APP样蛋白(APP/APLP)。由于可分泌蛋白的特定加工过程,甲状腺细胞是研究APP/APLP加工(特别是蛋白水解和碘化)以指示细胞表面表达以及研究这些功能调节的特别有用的细胞类型。
用丙硫氧嘧啶对大鼠进行体内处理,已知丙硫氧嘧啶会导致血清促甲状腺激素(TSH)水平升高并最大程度刺激甲状腺功能和生长。通过免疫荧光染色、十二烷基硫酸钠聚丙烯酰胺凝胶电泳和免疫印迹分析大鼠甲状腺组织和连续细胞系(FRTL - 5)中APP/APLP的表达。使用FRTL - 5细胞,通过对APP/APLP进行生物合成放射性标记和免疫沉淀分析其分泌和周转。
在静止甲状腺的滤泡细胞和滤泡腔中检测到APP/APLP。在丙硫氧嘧啶处理的大鼠中,腔内内容物的完全内吞清除与滤泡外空间中APP/APLP的明显可视化同时发生,在那里它与增殖的内皮细胞和成纤维细胞相关。在FRTL - 5细胞中,APP/APLP主要定位于高尔基体以及沿内吞途径的区室,包括溶酶体,APP/APLP在溶酶体中发生降解。成熟和未成熟形式的APP/APLP到达质膜后会被碘化。APP/APLP细胞外部分的一部分通过TSH依赖性切割和分泌机制从这些细胞释放到培养基中。
这些观察结果显示了甲状腺细胞中APP/APLP的表达、成熟和分泌以及TSH对这些过程的上调。未成熟APP/APLP的一部分通过其碘化表明出现在细胞表面。显然,这部分未成熟APP/APLP在运输到细胞表面的过程中逃脱了成熟。